ATE442840T1 - Nichtsprudelnde form von natrium-naproxen mit natriumhydrogencarbonat u.a. - Google Patents

Nichtsprudelnde form von natrium-naproxen mit natriumhydrogencarbonat u.a.

Info

Publication number
ATE442840T1
ATE442840T1 AT04761983T AT04761983T ATE442840T1 AT E442840 T1 ATE442840 T1 AT E442840T1 AT 04761983 T AT04761983 T AT 04761983T AT 04761983 T AT04761983 T AT 04761983T AT E442840 T1 ATE442840 T1 AT E442840T1
Authority
AT
Austria
Prior art keywords
sodium
fellowing
hydrogen carbonate
naproxen
sodium hydrogen
Prior art date
Application number
AT04761983T
Other languages
English (en)
Inventor
Peter Gruber
Martin Siegmund
Original Assignee
Bayer Consumer Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34529359&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE442840(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Consumer Care Ag filed Critical Bayer Consumer Care Ag
Application granted granted Critical
Publication of ATE442840T1 publication Critical patent/ATE442840T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04761983T 2003-10-30 2004-10-29 Nichtsprudelnde form von natrium-naproxen mit natriumhydrogencarbonat u.a. ATE442840T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH18482003 2003-10-30
PCT/CH2004/000655 WO2005041938A1 (en) 2003-10-30 2004-10-29 Non-effervescent form of sodium naproxen comprising i.a. sodium hydrogen carbonate

Publications (1)

Publication Number Publication Date
ATE442840T1 true ATE442840T1 (de) 2009-10-15

Family

ID=34529359

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04761983T ATE442840T1 (de) 2003-10-30 2004-10-29 Nichtsprudelnde form von natrium-naproxen mit natriumhydrogencarbonat u.a.

Country Status (15)

Country Link
US (1) US20070134317A1 (de)
EP (1) EP1684728B1 (de)
JP (1) JP2007509862A (de)
AR (1) AR046213A1 (de)
AT (1) ATE442840T1 (de)
BR (1) BRPI0415624A (de)
CA (1) CA2543709A1 (de)
CR (1) CR8406A (de)
DE (1) DE602004023220D1 (de)
EC (1) ECSP066587A (de)
ES (1) ES2333332T3 (de)
PA (1) PA8616101A1 (de)
PE (1) PE20050445A1 (de)
UY (1) UY28583A1 (de)
WO (1) WO2005041938A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1750677B1 (de) * 2004-05-28 2017-02-01 Imaginot Pty Ltd. Abgabesystem für eine orale therapeutische verbindung
AU2006226293B2 (en) 2005-03-22 2011-04-07 Losan Pharma Gmbh Solubilized ibuprofen
AU2006317530B2 (en) 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
GB201506755D0 (en) * 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
CA3001337C (en) * 2015-10-09 2023-12-12 Reckitt Benckiser Llc Pharmaceutical formulation
JP7163015B2 (ja) * 2016-10-31 2022-10-31 エスエス製薬株式会社 経口固形組成物
JP7163014B2 (ja) * 2016-10-31 2022-10-31 エスエス製薬株式会社 感冒薬
US11779541B2 (en) 2019-03-26 2023-10-10 Johnson & Johnson Consumer Inc. Immediate release dosage form

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
US5034416A (en) * 1988-01-19 1991-07-23 Smith Walton J Carboxylic acid compositions
PT96229B (pt) * 1989-12-22 1998-06-30 Syntex Pharma Int Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico
US5358717A (en) * 1989-12-22 1994-10-25 Syntex (U.S.A.) Inc. Directly-compressible naproxen or naproxen sodium compositions
IT1272149B (it) * 1993-03-26 1997-06-11 Zambon Spa Composizione farmeceutiche ad attivita' analgesica
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
JPH10298072A (ja) * 1997-04-17 1998-11-10 Panacea Biotec Ltd 非ステロイド性抗炎症剤の遷移金属錯体
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
US6165506A (en) * 1998-09-04 2000-12-26 Elan Pharma International Ltd. Solid dose form of nanoparticulate naproxen
US6383515B2 (en) * 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
EP1379226A2 (de) * 2001-04-10 2004-01-14 Zagros Pharma Inc. Tiermodell zur auswertung von analgetika
WO2002083110A2 (en) * 2001-04-10 2002-10-24 Zagros Pharma, Inc. Animal model for evaluating analgesics

Also Published As

Publication number Publication date
JP2007509862A (ja) 2007-04-19
CR8406A (es) 2008-04-25
PE20050445A1 (es) 2005-06-18
ECSP066587A (es) 2006-10-17
UY28583A1 (es) 2005-05-31
ES2333332T3 (es) 2010-02-19
AR046213A1 (es) 2005-11-30
PA8616101A1 (es) 2005-08-04
CA2543709A1 (en) 2005-05-12
EP1684728B1 (de) 2009-09-16
US20070134317A1 (en) 2007-06-14
WO2005041938A1 (en) 2005-05-12
EP1684728A1 (de) 2006-08-02
DE602004023220D1 (de) 2009-10-29
BRPI0415624A (pt) 2006-12-12

Similar Documents

Publication Publication Date Title
FI20031133A0 (fi) Sulkimella varustettu liitin
PT1506193E (pt) Pirazolopiridinas substituidas com carbonato
BR0307500B1 (pt) sachÊ com trÊs soldas.
NO20043696L (no) Gamma-sekretaseinhibitorer
IS2283B (is) Lekaskorða fyrir raflausnarker
DE60329912D1 (de) Ausgabe-behälter
BR0215457B1 (pt) cabeça de poço submarino com passagem.
DE60331626D1 (de) Fälschungssicheres Merkmal mit Linienmustern
DK1478851T3 (da) Offshore-vindmöllepark
NO20020265L (no) Fortöyningsanordning
ATE442840T1 (de) Nichtsprudelnde form von natrium-naproxen mit natriumhydrogencarbonat u.a.
DE60313852D1 (de) Elektrokatalytischer farbstoff
DK1335130T3 (da) Darrieus-vindmölle
DE50205601D1 (de) Einschraubventil
DE60236765D1 (de) Stromgesteuerter oszillator
NO20021944L (no) Slepebåt
DE60311138D1 (de) Pll mit symmetrischem quadrikorrelator
DE10311703B4 (de) Fahnenmast
DE50305415D1 (de) Folientastatur
NO20024303D0 (no) Böye
FR2843142B1 (fr) Faux-plafond a double paroi.
ITMO20020017V0 (it) Portaoggetti da spiaggia con chiusura a combinazione.
ITMO20020122A1 (it) Portaoggetti da spiaggia con chiusura a combinazione
TW543693U (en) Padlocks with containing spaces
PT9756U (pt) Bastidor com almas m esquadria para o fabrico de um fecho, em particular, tipo portao

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties